Recombinant peptide or protein production could be useful for coronavirus vaccine development: this approach is quite recently being used, as it reduces the allergic and autoimmune response.
This service is designed for Biotech companies developing SARS-CoV-2 new vaccines.
Materials to provide
- Details about the request
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
- Production following the specifications validated with the Expert